Results from an ASRM survey and recent randomized trials involving administration of estrogens to postmenopausal women have confused clinicians about when it is appropriate to provide estrogen to such individuals. This symposium will consider the evidence and the advisability of treating postmenopausal women with symptoms of estrogen deficiency. The symposium should be of interest to all clinicians who struggle with when and to whom to provide menopausal hormone therapy.
This CME symposium was held on Tuesday, October 24, 2006 at the American Society for Reproductive Medicine 2006 Annual Meeting in New Orleans, Louisiana. The symposium was supported by ASRM and educational grants from Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc.
|
 |
Background, Needs Assessment, and Review of White Paper
Rogerio A. Lobo, MD, Program Chair
Click Here to View |
|
|
 |
HT Heartfelt? Does it Strike Thee To the Breast?
Robert D. Langer, MD, MPH
Click Here to View |
|
|
 Q & A Session:
Should Symptomatic Menopausal Women Be
Offered Hormone Therapy?
Rogerio A. Lobo, MD, Program Chair
Robert D. Langer, MD, MPH
Click Here to View |
|
|
CME Posttest and Evaluation
1.5 CME credits available
Click Here |
|
|
|
|
|
